We provide the latest news
from the world of economics and financeBargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Friday, OPKO Health's CEO & Chairman, Phillip Frost, made a $211,195 buy of OPK, purchasing 163,997 shares at a cost of $1.29 a piece. Frost was up about 5.6% on the buy at the high point of today's trading session, with OPK trading as high as $1.36 in trading on Monday. OPKO Health is trading up about 3% on the day Monday. Before this latest buy, Frost purchased OPK on 17 other occasions during the past twelve months, for a total investment of $11.46M at an average of $1.05 per share.
And at Ouster, there was insider buying on Wednesday, by CEO Charles Angus Pacala who bought 16,000 shares for a cost of $12.33 each, for a trade totaling $197,283. This buy marks the first one filed by Pacala in the past year. Ouster is trading up about 0.5% on the day Monday. So far Pacala is in the green, up about 8.2% on their buy based on today's trading high of $13.34.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.